Cipla to launch molnupiravir in India to treat mild to moderate COVID-19 patients
Cipla to launch molnupiravir in India to treat mild to moderate COVID-19 patients

Cipla to launch molnupiravir in India to treat mild to moderate COVID-19 patients

Molnupiravir is an oral antiviral that inhibits the replication of multiple RNA viruses including SARS-CoV-2. The drug is used for the treatment of non-hospitalized patients with confirmed COVID-19 globally.

Subramanian K Article rating: 4.3

Cipla Limited announced today that it has been granted Emergency Use Authorization (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir in the country. Cipla plans to launch Molnupiravir under the brand name Cipmolnu. Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate COVID-19 at high risk of developing severe disease.

Roshni Nadar Malhotra - Richest woman in India is also the 52nd most powerful female in the world for 2021
Roshni Nadar Malhotra - Richest woman in India is also the 52nd most powerful female in the world for 2021

Roshni Nadar Malhotra - Richest woman in India is also the 52nd most powerful female in the world for 2021

The second-generation chairperson of one of the world’s leading tech companies HCL Technologies is the richest woman in India according to Hurun list of India’s richest women. The total Net worth of Roshni Nadar is Rs 54,850 crore.

Shreya Banthia Article rating: 3.2

In her strong leadership, HCL Technologies, India’s third-largest IT service company after TCS and Infosys have shown stellar performance with revenue of USD 10.17 billion or Rs 75,379 crore for FY 20-21. HCL Technologies have delivered the highest shareholder return of 138 per cent among largecap technology companies. HCL Technologies latest market capitalization is Rs 348516 crore under the leadership of Roshni Nadar Malhotra.

IPO listings in December 2021
IPO listings in December 2021

IPO listings in December 2021

Siddhi Sharma Article rating: 4.7

The primary market has been quite busy since the start of 2021 and continued the momentum in December too. In December 2021 fourteen IPOs were listed.

T20 breakout stocks: Best swing trading stocks to keep an eye on!
T20 breakout stocks: Best swing trading stocks to keep an eye on!

T20 breakout stocks: Best swing trading stocks to keep an eye on!

Karan Dsij Article rating: 3.5

Certainly, with the relative outperformance from the broader markets, the market participants would be looking for some opportunities on the long side. Hence, we have come out with a list of the stocks based on the T20 breakout system.

Indices end marginally lower; auto stocks rally higher
Indices end marginally lower; auto stocks rally higher

Indices end marginally lower; auto stocks rally higher

Rohit Kale Article rating: 3.5

Nifty ended at day at 17,213, lower by 19 points or 0.11 per cent while Sensex tanked nearly 200 points. However, Nifty Smallcap ended higher over half a per cent while Nifty Midcap ended flat.

RSS
First19521953195419551957195919601961Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR